Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) hit a new 52-week high on Friday . The company traded as high as $54.00 and last traded at $54.00, with a volume of 243 shares. The stock had previously closed at $45.85.
Wall Street Analyst Weigh In
Separately, Chardan Capital raised Pharma Mar to a “strong-buy” rating in a research report on Thursday, August 1st.
Check Out Our Latest Stock Report on Pharma Mar
Pharma Mar Price Performance
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments.
Read More
- Five stocks we like better than Pharma Mar
- What is a support level?
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- 3 Fintech Stocks With Good 2021 Prospects
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- How to Read Stock Charts for Beginners
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
